Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Tuberculosis

  Free Subscription


29.05.2017

2 Antimicrob Agents Chemother
2 Clin Infect Dis
4 Eur Respir J
1 J Antimicrob Chemother
1 J Infect Dis
1 Lancet Infect Dis
1 PLoS Med
7 PLoS One


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Antimicrob Agents Chemother

  1. FOFANA MO, Dowdy DW
    Reply to Anthony et al., "Protecting Pyrazinamide, a Priority for Improving Outcomes in Multidrug-Resistant Tuberculosis Treatment".
    Antimicrob Agents Chemother. 2017;61.
    PubMed     Text format    

  2. ANTHONY RM, Cynamon M, Hoffner S, Werngren J, et al
    Protecting Pyrazinamide, a Priority for Improving Outcomes in Multidrug-Resistant Tuberculosis Treatment.
    Antimicrob Agents Chemother. 2017;61.
    PubMed     Text format    


    Clin Infect Dis

  3. FURIN J, Cox H
    To Test or Not to Test? Ending the Age-Old Debate for Drug-Resistant Tuberculosis.
    Clin Infect Dis. 2017 May 26. doi: 10.1093.
    PubMed     Text format    

  4. AIBANA O, Franke MF, Huang CC, Galea JT, et al
    Impact of Vitamin A and Carotenoids on the Risk of Tuberculosis Progression.
    Clin Infect Dis. 2017 May 20. doi: 10.1093.
    PubMed     Text format     Abstract available


    Eur Respir J

  5. OLARU ID, Heyckendorf J, Andres S, Kalsdorf B, et al
    Bedaquiline-based treatment regimen for multidrug-resistant tuberculosis.
    Eur Respir J. 2017;49.
    PubMed     Text format    

  6. RAHMAN MT, Codlin AJ, Rahman MM, Nahar A, et al
    An evaluation of automated chest radiography reading software for tuberculosis screening among public- and private-sector patients.
    Eur Respir J. 2017;49.
    PubMed     Text format     Abstract available

  7. GUGLIELMETTI L
    Bedaquiline for the treatment of multidrug-resistant tuberculosis: another missed opportunity?
    Eur Respir J. 2017;49.
    PubMed     Text format    

  8. MILLER C, Lonnroth K, Sotgiu G, Migliori GB, et al
    The long and winding road of chest radiography for tuberculosis detection.
    Eur Respir J. 2017;49.
    PubMed     Text format    


    J Antimicrob Chemother

  9. MAITRE T, Petitjean G, Chauffour A, Bernard C, et al
    Are moxifloxacin and levofloxacin equally effective to treat XDR tuberculosis?
    J Antimicrob Chemother. 2017 May 23. doi: 10.1093.
    PubMed     Text format     Abstract available


    J Infect Dis

  10. YAO Y, Lai R, Afkhami S, Haddadi S, et al
    A novel virus-vectored respiratory mucosal vaccine enhances anti-tuberculosis immunity in a humanized model system.
    J Infect Dis. 2017 May 20. doi: 10.1093.
    PubMed     Text format     Abstract available


    Lancet Infect Dis

  11. KUNKEL A, Furin J, Cohen T
    Population implications of the use of bedaquiline in people with extensively drug-resistant tuberculosis: are fears of resistance justified?
    Lancet Infect Dis. 2017 May 19. pii: S1473-3099(17)30299.
    PubMed     Text format     Abstract available


    PLoS Med

  12. BINAGWAHO A, Kankindi I, Kayirangwa E, Nyemazi JP, et al
    Transitioning to Country Ownership of HIV Programs in Rwanda.
    PLoS Med. 2016;13:e1002075.
    PubMed     Text format     Abstract available


    PLoS One

  13. LEMPP JM, Zajdowicz MJ, Hankinson AL, Toney SR, et al
    Assessment of the QuantiFERON-TB Gold In-Tube test for the detection of Mycobacterium tuberculosis infection in United States Navy recruits.
    PLoS One. 2017;12:e0177752.
    PubMed     Text format     Abstract available

  14. OPERARIO DJ, Koeppel AF, Turner SD, Bao Y, et al
    Prevalence and extent of heteroresistance by next generation sequencing of multidrug-resistant tuberculosis.
    PLoS One. 2017;12:e0176522.
    PubMed     Text format     Abstract available

  15. CHOI SR, Britigan BE, Moran DM, Narayanasamy P, et al
    Gallium nanoparticles facilitate phagosome maturation and inhibit growth of virulent Mycobacterium tuberculosis in macrophages.
    PLoS One. 2017;12:e0177987.
    PubMed     Text format     Abstract available

  16. MOHR E, Daniels J, Beko B, Isaakidis P, et al
    DOT or SAT for Rifampicin-resistant tuberculosis? A non-randomized comparison in a high HIV-prevalence setting.
    PLoS One. 2017;12:e0178054.
    PubMed     Text format     Abstract available

  17. ABAYE GE, Abebe T, Worku A, Tolessa D, et al
    Detection of Mycobacterium tuberculosis from the stool of HIV sero-positive individuals suspected of pulmonary tuberculosis.
    PLoS One. 2017;12:e0177529.
    PubMed     Text format     Abstract available

  18. ZHANG L, Cheng X, Bian S, Song Y, et al
    Utility of Th1-cell immune responses for distinguishing active tuberculosis from non-active tuberculosis: A case-control study.
    PLoS One. 2017;12:e0177850.
    PubMed     Text format     Abstract available

  19. XIAO Y, Yu S, Xue Q, Lang S, et al
    A scoring system to effectively evaluate central nervous system tuberculosis in patients with military tuberculosis.
    PLoS One. 2017;12:e0176651.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Tuberculosis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: